Progesterone Test
The progesterone test measures serum progesterone, the principal hormone of the luteal phase and early pregnancy. Its main clinical use is confirming ovulation, with a mid-luteal rise providing biochemical evidence that a corpus luteum has formed.
1
Biomarkers
Blood (serum)
Sample
1–3 business days
Turnaround
No — however, collection timing relative to the menstrual cycle is essential and should be documented (typically mid-luteal, around 7 days before the expected period)
Fasting
What is the Progesterone test?
The Progesterone Test measures serum progesterone, the principal hormone of the luteal phase and early pregnancy. Its dominant clinical role is the confirmation of ovulation: a mid-luteal rise demonstrates that a corpus luteum has formed and is producing hormone, making it a cornerstone of subfertility assessment. Within the reproductive endocrine landscape, progesterone is interpreted strictly in relation to cycle timing and is rarely informative without it. It complements measurements of LH, FSH, and oestradiol in characterising the menstrual cycle, supports monitoring of ovulation-induction and luteal-support protocols in assisted reproduction, and assists in evaluating early pregnancy where low levels may signal a non-viable or ectopic gestation. In postmenopausal and non-pregnant contexts, progesterone is used selectively rather than as a routine screen.
What does the Progesterone test measure?
Progesterone is a C21 steroid hormone synthesised principally by the corpus luteum after ovulation, by the adrenal cortex, and by the placenta during pregnancy. It is derived from pregnenolone and serves as a precursor for other steroid hormones. Circulating progesterone is largely bound to albumin and corticosteroid-binding globulin, with a short half-life of minutes to hours. Levels fluctuate markedly across the menstrual cycle, peaking in the mid-luteal phase, and rise substantially in pregnancy.
Progesterone measurement confirms ovulation, with a mid-luteal rise being the classical biochemical evidence that ovulation has occurred. It supports luteal-phase assessment in subfertility, monitoring of assisted reproduction and progesterone supplementation, and evaluation of early pregnancy viability. Because levels change rapidly across the cycle, the timing of collection relative to the menstrual cycle is essential for meaningful interpretation.
Why is the Progesterone test ordered?
- Confirmation of ovulation in subfertility assessment — a mid-luteal progesterone, drawn around 7 days before the expected period, provides biochemical evidence that ovulation has occurred
- Investigation of luteal-phase adequacy in women with recurrent early pregnancy loss or suspected luteal insufficiency
- Monitoring of ovulation-induction cycles and luteal support during assisted reproductive technology protocols
- Evaluation of early pregnancy viability where low progesterone may support suspicion of a failing or ectopic pregnancy, interpreted alongside serial hCG
- Assessment of menstrual irregularity or amenorrhoea as part of a reproductive hormone profile with LH, FSH, and oestradiol
- Monitoring of progesterone supplementation in patients receiving exogenous progesterone for luteal support or hormone therapy
- Investigation of suspected congenital adrenal hyperplasia or adrenal steroidogenic disorders as part of a broader steroid panel
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
No — however, collection timing relative to the menstrual cycle is essential and should be documented (typically mid-luteal, around 7 days before the expected period)
Collection method
Venipuncture at patient service centre
Turnaround
1–3 business days
Collection notes
Document the cycle day and any exogenous progesterone or ovulation-induction therapy. For ovulation confirmation, draw in the mid-luteal phase. Advise patients to withhold high-dose biotin supplementation for 48–72 hours prior to collection to avoid immunoassay interference.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells per LabCorp protocol. Specimen stable refrigerated; follow LabCorp transport guidelines.
What can affect Progesterone results?
Progesterone varies more than tenfold across the cycle, peaking mid-luteal and falling to baseline in the follicular phase. A specimen drawn at the wrong cycle point is uninterpretable; collection timing must be documented relative to the menstrual cycle.
Supplemental progesterone raises measured levels directly, while some synthetic progestins may or may not cross-react with the assay depending on its design. Treatment and product should be documented.
Progesterone rises progressively in pregnancy due to corpus luteum and then placental production, with values far exceeding luteal-phase concentrations.
Corpus luteum progesterone is secreted in pulses, so a single mid-luteal value can vary substantially within the same day. A borderline result may warrant repeat sampling.
Clomiphene, letrozole, and gonadotrophin stimulation can produce multiple corpora lutea, elevating luteal progesterone above natural-cycle expectations.
Biotin can interfere with streptavidin-biotin immunoassay platforms, producing falsely altered progesterone depending on assay architecture. Patients should withhold high-dose biotin for 48–72 hours before collection.
What do Progesterone results mean?
Elevated
Elevated progesterone in the luteal phase confirms ovulation and an active corpus luteum. Markedly elevated values may reflect pregnancy, multiple corpora lutea from ovulation induction, exogenous progesterone, or, rarely, a progesterone-producing ovarian or adrenal lesion.
Normal
Interpretation depends entirely on cycle phase. A follicular-phase value is expected to be low, while a mid-luteal value above the ovulation threshold supports normal ovulatory function. A result without documented cycle timing cannot be classified reliably.
Reduced
A low mid-luteal progesterone suggests anovulation, a luteal-phase defect, or mistimed sampling. In early pregnancy, low progesterone raises concern for a non-viable or ectopic gestation and should be interpreted alongside serial hCG.
Note: Progesterone is meaningless without cycle context — the same value can be normal or abnormal depending on timing. Pulsatile secretion means a single value may not represent the true luteal peak, and exogenous progesterone or biotin can distort results. Always interpret alongside the menstrual history and, where relevant, hCG.
Frequently asked questions
Its principal use is confirming ovulation. A mid-luteal rise in progesterone provides biochemical evidence that a corpus luteum has formed and is producing hormone, indicating ovulation has occurred.
How to access the Progesterone test
The Progesterone reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: June 2, 2026
Last reviewed: June 2, 2026
- Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. (2015)
- Wathen NC, et al. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase. Br Med J. (1984)
- Verhaegen J, et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis. BMJ. (2012)
- Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility — luteal phase and ovulation assessment. (2005)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.